Transforming Preclinical Research

OmniCarta™ is revolutionising pre-clinical drug safety and efficacy with a next-generation platform that reveals the full biodistribution down to single cell resolution across multiple tissues.

About OmniCarta™

OmniCarta™ is a Newcastle University spin-out.
Developing cutting-edge preclinical research platforms.
Mapping drug biodistribution and systemic effects innovatively.

OmniCarta: Cardio

OmniCarta: Senolytics

In Vivo Imaging

Utilising sophisticated imaging techniques to visualize drug bio-distribution in real-time.

Blood and Serum Biomarker Analysis

Employing advanced full spectrum flow cytometry and serum proteomics to analyse complex cellular and molecular responses to therapies.

Multiplexed Spatial Proteomics

Integrating spatial proteomic imaging for a detailed understanding of tissue environments.

Powered by AI

Our bespoke STENCIL (Spatial Triage Engine for Navigating Cellular Imaging Locations) software provides unrivalled decision making in both tissue selection and analysis making comprehensive spatial proteomics a cost effective readout.

I hereby agree that this data will be stored and processed for the purpose of establishing contact. I am aware that I can revoke my consent at any time.*

* Please fill in all the required fields.
Message was successfully sent

Get in touch

E-mail: info@omnicarta.net

Address:  Newcastle University, NE2 4EE

 

©Copyright. All rights reserved.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.